Medindia LOGIN REGISTER
Medindia
Advertisement

ShangPharma Announces First Quarter 2011 Results

Thursday, May 19, 2011 General News
Advertisement

SHANGPHARMA CORPORATION

RECONCILIATION OF GAAP TO NON-GAAP FINANACIAL DATA

(in thousands of U.S. dollars, except for ADS(1) data and per ADS data)



Three months ended

March 31,

2010

2011

%

GAAP gross profit

6,940

8,000

15.3%

GAAP gross margin

35.2%

32.3%

Adjustments:

   Share-based compensation

125

598

378.4%

Non-GAAP gross profit

7,065

8,598

21.7%

Non-GAAP gross margin

35.8%

34.7%



GAAP operating expenses

(3,815)

(5,522)

44.7%

Adjustments:

   Share-based compensation

51

771

1411.8%

Non-GAAP operating expenses

(3,764)

(4,751)

26.2%

GAAP profit from operations

3,125

2,478

-20.7%

GAAP operating margin

15.8%

10.0%

Adjustments:

   Share-based compensation

176

1,369

677.8%

Non-GAAP profit from operations

3,301

3,847

16.5%

Non-GAAP operating margin

16.7%

15.5%



GAAP net income

2,732

3,012

10.2%

GAAP net margin

13.8%

12.2%

Adjustments:

   Share-based compensation

176

1,369

677.8%

Non-GAAP net income

2,908

4,381

50.7%

Non-GAAP net margin

14.7%

17.7%



GAAP net income attributable to ShangPharma Corporation's ordinary shareholders per ADS, diluted :

0.18

0.16

-11.1%

Adjustments:

   Share-based compensation

0.01

0.07



Non-GAAP net income attributable to ShangPharma Corporation's ordinary shareholders per ADS, diluted:

0.19

0.23

21.1%

Weighted average ADS outstanding - basic (Non-GAAP)

11,555,888

18,644,444

Weighted average ADS outstanding - diluted (Non-GAAP)

11,606,506

18,947,692

(1) Each ADS represents 18 ordinary shares.

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close